These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 11337363)

  • 1. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
    Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy.
    Kim HW; Kim BC; Song CY; Kim JH; Hong HK; Lee HS
    Kidney Int; 2004 Nov; 66(5):1859-65. PubMed ID: 15496156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression.
    Han DC; Isono M; Chen S; Casaretto A; Hong SW; Wolf G; Ziyadeh FN
    Kidney Int; 2001 Apr; 59(4):1315-23. PubMed ID: 11260392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
    Song SL; Gong ZJ; Zhang QR; Huang TX
    World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
    Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
    Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.
    Song CY; Kim BC; Hong HK; Lee HS
    Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
    Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
    Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal TGF-beta system in the db/db mouse model of diabetic nephropathy.
    Cohen MP; Sharma K; Guo J; Eltayeb BO; Ziyadeh FN
    Exp Nephrol; 1998; 6(3):226-33. PubMed ID: 9639038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
    Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    Poncelet AC; Schnaper HW
    J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1.
    Runyan CE; Schnaper HW; Poncelet AC
    J Biol Chem; 2004 Jan; 279(4):2632-9. PubMed ID: 14610066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells.
    Hayashida T; Schnaper HW
    J Am Soc Nephrol; 2004 Aug; 15(8):2032-41. PubMed ID: 15284289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
    Runyan CE; Schnaper HW; Poncelet AC
    J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo.
    Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 2002 Aug; 119(2):499-506. PubMed ID: 12190876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.